BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25959926)

  • 21. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
    Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
    Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An optoelectronic cervical cancer screening system for screening cervical cancer: comparison with cervical cytology].
    He XK; Luo XP; Mao LZ; Chen GY; Li Y; Zhang JY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2304-6. PubMed ID: 20965832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
    Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
    Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images.
    William W; Ware A; Basaza-Ejiri AH; Obungoloch J
    Biomed Eng Online; 2019 Feb; 18(1):16. PubMed ID: 30755214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.
    Richardson LA; El-Zein M; Ramanakumar AV; Ratnam S; Sangwa-Lugoma G; Longatto-Filho A; Cardoso MA; Coutlée F; Franco EL;
    Cancer Cytopathol; 2015 Dec; 123(12):745-54. PubMed ID: 26230283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images.
    William W; Ware A; Basaza-Ejiri AH; Obungoloch J
    Comput Methods Programs Biomed; 2018 Oct; 164():15-22. PubMed ID: 30195423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity and reliability of using a self-lavaging device for cytology and HPV testing for cervical cancer screening: findings from a pilot study.
    Jones HE; Mansukhani MM; Tong GX; Westhoff CL
    PLoS One; 2013; 8(12):e82115. PubMed ID: 24376516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractal Analysis of Cancer Cell Surface.
    Sokolov I; Dokukin ME
    Methods Mol Biol; 2017; 1530():229-245. PubMed ID: 28150205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of cancerous cervical cells using physical adhesion of fluorescent silica particles and centripetal force.
    Gaikwad RM; Dokukin ME; Iyer KS; Woodworth CD; Volkov DO; Sokolov I
    Analyst; 2011 Apr; 136(7):1502-6. PubMed ID: 21305062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study.
    Haguenoer K; Giraudeau B; Gaudy-Graffin C; de Pinieux I; Dubois F; Trignol-Viguier N; Viguier J; Marret H; Goudeau A
    Gynecol Oncol; 2014 Aug; 134(2):302-8. PubMed ID: 24905772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.
    Zhao FH; Lin MJ; Chen F; Hu SY; Zhang R; Belinson JL; Sellors JW; Franceschi S; Qiao YL; Castle PE;
    Lancet Oncol; 2010 Dec; 11(12):1160-71. PubMed ID: 21075054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.
    Balasubramanian A; Kulasingam SL; Baer A; Hughes JP; Myers ER; Mao C; Kiviat NB; Koutsky LA
    J Low Genit Tract Dis; 2010 Jul; 14(3):185-95. PubMed ID: 20592553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Importance of the Pap smear in the age of HPV testing].
    Ghisu GP
    Ther Umsch; 2021; 78(2):93-98. PubMed ID: 33615865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
    Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
    Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of addition of HPV DNA testing to the cytology based cervical cancer screening and triage of findings with p16/Ki67 immunocytochemistry staining in 35 and 45 years old women LIBUSE trial data analysis.
    Sláma J; Dvořák V; Trnková M; Skřivánek A; Hurdálková K; Ovesná P; Nováčková M
    Ceska Gynekol; 2020; 85(6):368-374. PubMed ID: 33711896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards nonspecific detection of malignant cervical cells with fluorescent silica beads.
    Iyer S; Woodworth CD; Gaikwad RM; Kievsky YY; Sokolov I
    Small; 2009 Oct; 5(20):2277-84. PubMed ID: 19415648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
    Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
    Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.